Monocytes rapidly mobilize and rapidly differentiate in response to microbial challenges. Although monocytes are recruited to diverse host tissues and are implicated in innate and adaptive responses to viral and other microbial pathogens, their compartment-specific contributions to host defense remain incompletely defined. In part, our limited understanding of the role of monocytes in antimicrobial defense stems from the fact that selective in vivo depletion of monocytes has been difficult to achieve. Our results using a CCR2 depleter mouse strain demonstrate an essential role for monocytes in the priming and expansion of CD4 T cell responses following inhalation of a microbial pathogen. Loss of CD4 T cell priming following monocyte depletion correlates with a marked decrease in transport of fungal conidia to lung-draining MLNs and an ensuing defect in fungal clearance from the lung, thus implicating CCR2+Ly6Chi monocytes and derivative CD11b+ DCs in this critical early step in the adaptive immune response.
We found that transferred BM monocytes rapidly differentiate in the presence of infection and express high levels of CD11c and MHC class II, giving rise to lung CD11b
+ DCs. Under these conditions, we did not observe monocyte differentiation into CD103
+ DCs or pulmonary macrophages (data not shown). Furthermore, we did not observe CD11c and MHC class II upregulation upon transfer of cells into naive mice. It is likely that microbially induced inflammatory responses promote monocyte differentiation into CD11b
+ DCs with the capacity to take up and process microbial cargo at the portal of entry. CD11b
+ and CD103
+ lung DCs have been reported to discriminate between soluble and particulate forms of a model antigen, with uptake of the soluble form primarily by CD11b
+ DCs and the particulate form primarily by CD103
+ DCs (
Jakubzick et al., 2008a). However, our results suggest that CD11b
+ DCs bind inhaled conidia, particles with an average diameter of 2–4 μm. In murine models of tuberculosis and leishmaniasis, CD11b
+ DCs take up fluorescent mycobacteria and parasites at infection sites and remain associated with the labeled microbes in the draining LNs (
Leon et al., 2007;
Wolf et al., 2007). Influenza virus nucleo-protein is found in the cytoplasm of migratory CD11b
+ and plamacytoid DCs isolated from the lung-draining lymph nodes. (
GeurtsvanKessel et al., 2008). An explanation for the differential uptake of microbial antigen by CD103
− and CD103
+ DCs is the distinct complement of phagocytic receptors expressed by these DC subsets. Recent microarray analyses demonstrate that mRNA levels of receptors (e.g., dectin-1 and CD209) involved in conidial uptake are higher in CD103
− than in CD103
+ DCs (
del Rio et al., 2008;
Serrano-Gomez et al., 2004). This difference may explain the in vivo difference in fungal cell uptake by CD11b
+ and CD103
+ lung DCs.
Much has been learned recently about the development of tissue DCs from precursors in the BM. Geissmann and colleagues identified a common macrophage and DC precursor (MDP) (
Fogg et al., 2006) that gives rise to DC subsets both in lymphoid and nonlymphoid tissues. However, splenic conventional CD8α
− and CD8α
+DCs (cDCs) develop in an Flt3L-dependent manner (
Waskow et al., 2008) via a common DC precursor (CDP) in the BM and a pre-DC intermediate that can traffic from the BM to the spleen (
Liu et al., 2007,
2009;
Naik et al., 2006,
2007;
Onai et al., 2007). Monocytes and descendent cells arise from MDPs as well (
Auffray et al., 2009a;
Fogg et al., 2006), albeit via a distinct developmental pathway (
Liu et al., 2009). Recent studies using parabiosis, latex bead labeling, and adoptive transfer techniques found that circulating monocytes (
Jakubzick et al., 2008b;
Landsman and Jung, 2007;
Landsman et al., 2007) have the capacity to give rise to lung DCs and macrophages in the steady state, with CCR2
+Ly6C
hi monocytes preferentially giving rise to CD103
+ DCs and Ly6C
lo monocytes preferentially giving rise to CD11b
+ DCs (
Jakubzick et al., 2008b). It is clear that these steady-state pathways of monocyte differentiation are redirected during microbial infection (
Serbina et al., 2008). For example, Ly6C
hi monocytes infiltrating the spleens of
Listeria monocytogenes-infected mice differentiate into TNF and iNOS-producing DCs (Tip-DCs) that are largely uninfected (
Serbina et al., 2003). In contrast, in the setting of respiratory
A. fumigatus infection, Ly6C
hi monocytes differentiate into CD11b
+ DCs upon uptake of fungal conidia. This may explain differences in our study from results seen in the steady state (
Jakubzick et al., 2008b).
The distinct developmental pathways of lung and splenic DCs likely contribute to the different degree of DC ablation noted in lung and splenic subsets in toxin-treated CCR2 depleter mice (). Depletion of pulmonary CD11b
+ and CD103
+ DCs upon DT treatment of CCR2-DTR mice may result from depletion of monocyte precursors, but it is possible that tissue DC populations recently derived from monocytes continue to express DTR and thus are eliminated by toxin treatment. The delayed kinetics of lung DC subset depletion, however, suggests that monocyte loss is a more likely explanation for DC loss. Furthermore, the half-life of airway DCs is short. Holt and colleagues estimated a turnover time of ~2 days based on BM chimera experiments (
Holt et al., 1994). In addition, respiratory DCs undergo basal migration to secondary lymphoid tissues via afferent lymphatics (
Legge and Braciale, 2003). It is thus likely that pulmonary DC subsets are sensitive to the levels of circulating precursor cells, particularly following microbial challenge or in inflammatory states.
The finding that splenic CD4 T cell responses remain intact whereas pulmonary CD4 T cell responses are impaired may appear surprising, given the observation that MDPs are targeted in CCR2 depleter mice following toxin administration. Though bromodeoxyuridine labeling experiments suggests that both splenic subsets have half-lives on the order of 1.5–3 days (
Kamath et al., 2000), more recent data show that splenic DCs may undergo limited cell division in situ (
Liu et al., 2007) and extend the half-life of lymphoid organ DCs to 5–7 days. This latter estimate may contribute to differences in depletion seen in our experiments, given DT-induced depletion of the common MDP precursor. Consistent with this view, we observed that splenic cDCs were completely depleted in CCR2 depleter mice if the DT injection schedule was extended to four injections over 8 days (data not shown).
How do CCR2-expressing monocytes influence T cell responses? In our experiments, we demonstrate that they are necessary to transport conidia to draining lymph nodes. Although we demonstrate that monocyte-derived CD11b
+ DCs prime naive T cells ex vivo, we cannot be certain that they are performing this function in vivo. Thus, the possibility remains that monocytes transport conidia to lymph nodes and then transfer antigen to lymph node-resident DCs. During influenza virus infection, this scenario appears highly likely for the priming of CD8 T cell responses by MLN resident CD11b
− CD8α
+ DCs (
Belz et al., 2004) or CD11b
− CD8α
− DCs and CD4 T cell responses by MLN CD11b
− CD8α
− DCs (
GeurtsvanKessel et al., 2008), given that these subsets do not participate in viral antigen delivery to the MLN. The recent development of mice with defined genetic lesions in lymph node-resident CD8α
+ DC development (
Hildner et al., 2008) may provide a framework to address these questions in more detail.
Invasive aspergillosis (IA) is a disease of the highly immunocompromised host, occurring most commonly in patients undergoing allogeneic BM transplantation (
Segal, 2009). Although neutropenia is a well-appreciated risk factor for invasive fungal infection, recent studies have demonstrated that human monocyte subsets can also directly inhibit germination of
A. fumigatus conidia (
Serbina et al., 2009a). Whether human or murine monocytes play a critical role for the success of vaccine strategies that target IA remains an important line of investigation. Preclinical studies have evaluated a large number of proteinaceous, lipidic, and carbohydrate antigens in combination with adjuvants or DCs as vaccine candidates (
Bozza et al., 2009;
Cenci et al., 2000;
Torosantucci et al., 2005,
2009). Our demonstration that selective depletion of monocytes in the setting of
A. fumigatus infection abrogates pathogen-specific CD4 T cell responses suggests that temporary loss of monocytes in clinical settings has important implications for CD4 T cell-dependent vaccination strategies and the development of adaptive antifungal defenses.